Lillys technological lead is set to widen further with its next-generation candidate retatrutide, a triple-pathway therapy that has delivered transformative Phase III trial results
Growth hormone-releasing hormone (GHRH) boosts GH release from the pituitary, while somatostatin (also called growth hormone-blocking hormone) suppresses GH release
The STEP-1 trial reported that the maximum weekly dose of semaglutide (2.4mg) can lead to GI reactions such as nausea, diarrhea, vomiting, and constipation
This action supports immune balance across skin, gastrointestinal tissue, joints, and connective tissue
Is bloating worse with higher semaglutide doses
More importantly, many people have underlying issues that block B12 absorption, regardless of what they eat